Profile of Nagoya University Hospital 2012

• Idea/Basic Decision
• Declaration Regarding Patients' Rights and Responsibilities
• Message From the Director

• Idea, Basic Decision, History
• Organization Chart of University Hospital
• Organization Chart of Administration Office
• Chronological List of Directors of University Hospital
• Established Date of Clinical Departments
• Clinical Departments
• Legal Authorization of Medical Services
• University Hospital Staff, Number of Staffs
• Number of Beds
• Patient Services in the University Hospital in 2011
• Clinical Indicator
• Access

Thoracic Surgery

Director YOKOI, Kohei (Associate Professor)   3E

Extensive achievements to provide relief in diseases including lung cancer

Our department specializes in surgical treatment of thoracic malignant tumor (e.g. lung cancer) and benign disease (e.g. pneumothorax).

Medical Care System

Nine full-time doctors (including seven thoracic surgery specialists) provide medical care. Outpatient days are Tuesday and Thursday. Surgery days are Monday, Wednesday, and Friday. Treatment strategies for patients are discussed and determined every Friday at the joint conference of Respirology, Surgery, and Radiology.

Target Disease

Main target diseases are thoracic malignant tumor such as primary lung cancer, metastatic lung cancer, pleural mesothelioma, and thymoma. Non-neoplastic benign diseases such as myasthenia gravis requiring thymectomy, inflammatory lung disease, pyothorax, pneumothorax, chest injury, and congenital pulmonary malformation are also our target diseases.

Strong Fields

We have safely and successfully performed surgeries in patients with locally advanced lung cancer and malignant pleural mesothelioma, which require specialized perioperative management, and in patients with severe comorbidities (e.g. chronic obstructive pulmonary disease, heart disease, diabetes, and dialysis).

Clinical Results

The annual total number of surgeries in 2011 was 302 (156 patients with lung cancer, 39 patients with mediastinal tumor, 41 patients with metastatic lung tumor, five patients with malignant pleural mesothelioma, 61 patients with other diseases; there was one patient who died in-hospital day). About half of the surgeries were performed for lung cancer.

Specialized Outpatient Clinic

Although we do not have specialized outpatient clinics, our department is characterized by extensive experience in treatment of diseases, especially in lung cancer, malignant pleural mesothelioma, and advanced invasive thymoma. We welcome patients seeking second opinions.

Advanced Medicine and Research

We conduct various basic research and clinical studies to establish new evidence. Currently, a phase II study of postoperative adjuvant chemotherapy and clinical studies on topics such as multimodality therapy for lung cancer with thoracic wall invasion and investigation of limited surgery for early-stage lung cancer are ongoing.